1 story in the last 7 days
The latest syntax bio news, distilled by AI into sharp ~100-word summaries. ByteBrief tracks syntax bio across dozens of tech sources and brings you only what matters, updated hourly. Tap any story for the full brief, or open the original source.
Syntax Bio raised its Series A round to over $25 million. The company focuses on developing programmable cell therapies. The additional funding will support further research and development efforts.
Summaries by ByteBrief